GSEA-SNP: applying gene set enrichment analysis to SNP data from genome-wide association studies
暂无分享,去创建一个
Marit Holden | Leszek Wojnowski | Shiwei Deng | Bettina Kulle | M. Holden | L. Wojnowski | B. Kulle | Shiwei Deng
[1] M. Orešič,et al. Pathways to the analysis of microarray data. , 2005, Trends in biotechnology.
[2] T. Force,et al. p38 mitogen-activated protein kinase: a future target for heart failure therapy? , 2006, Journal of the American College of Cardiology.
[3] D. Clayton,et al. Genome-wide association studies: theoretical and practical concerns , 2005, Nature Reviews Genetics.
[4] Kai Wang,et al. Pathway-based approaches for analysis of genomewide association studies. , 2007, American journal of human genetics.
[5] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[6] R Aikawa,et al. MAPK superfamily plays an important role in daunomycin-induced apoptosis of cardiac myocytes. , 1999, Circulation.
[7] N Risch,et al. The Future of Genetic Studies of Complex Human Diseases , 1996, Science.
[8] M. Daly,et al. Genome-wide association studies for common diseases and complex traits , 2005, Nature Reviews Genetics.
[9] Ye Xiong,et al. Attenuation of doxorubicin-induced contractile and mitochondrial dysfunction in mouse heart by cellular glutathione peroxidase. , 2006, Free radical biology & medicine.
[10] Leszek Wojnowski,et al. Dystrophin‐deficiency increases the susceptibility to doxorubicin‐induced cardiotoxicity , 2007, European journal of heart failure.
[11] Joy Joseph,et al. Doxorubicin-induced apoptosis: Implications in cardiotoxicity , 2002, Molecular and Cellular Biochemistry.
[12] Joseph L. Gastwirth,et al. Trend Tests for Case-Control Studies of Genetic Markers: Power, Sample Size and Robustness , 2002, Human Heredity.
[13] Yongchao Ge. Resampling-based Multiple Testing for Microarray Data Analysis , 2003 .
[14] J. Klein,et al. Suppression by Metallothionein of Doxorubicin-induced Cardiomyocyte Apoptosis through Inhibition of p38 Mitogen-activated Protein Kinases* , 2000, The Journal of Biological Chemistry.
[15] M. Pfreundschuh,et al. NAD(P)H Oxidase and Multidrug Resistance Protein Genetic Polymorphisms Are Associated With Doxorubicin-Induced Cardiotoxicity , 2005, Circulation.
[16] A Bast,et al. The new cardioprotector Monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro , 2003, British Journal of Cancer.